Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
WPP plc
(NYSE: WPP)
|
2:51 PM UTC, 04/22/25 | |||
---|---|---|---|---|
Last: $35.92 | Change: +0.74 | %Change: +2.12% | Volume: 77,015 |
11:15 AM EDT, 10/15/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were were sharply lower late Tuesday morning, falling 1.75% to 1,410.73 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Ericsson (ERIC) and furniture maker Natuzzi (NTZ), which climbed 11% and 9.7% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and brewing company Anheuser-Busch InBev (BUD), which increased 2.4% and 1.1% respectively.
The decliners from continental Europe were led by oil and gas company TotalEnergies (TTE) and petroleum refiner Equinor (EQNR), which dropped 4.6% and 4.1% respectively. They were followed by oil and gas company Eni (E) and biotech firm BioNTech (BNTX), which lost 3.1% and 2.3% respectively.
From the UK and Ireland, the gainers were led by cruise line operator Carnival (CUK) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which rose 6.2% and 1.6% respectively. They were followed by utilities company National Grid (NGG) and communications company WPP (WPP), which were up 1.3% and 1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and oil and gas company BP (BP), which fell 6.5% and 3.2% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and oil and gas company Shell (SHEL), which were down 3.1% each.
http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.